Acquisition Accelerates Expansion of Cold Chain Capabilities Throughout Europe and Latin America
UPS (NYSE: UPS) announced today that it has closed on the acquisition of Bomi Group, an industry-leading multi-national healthcare logistics provider. Through the acquisition, the company's healthcare unit, UPS Healthcare, will add temperature-controlled facilities in 14 countries, and 3,000 highly-skilled employees to the UPS team across Europe and Latin America.
The company will operate under the new name Bomi Group, a UPS Company. Bomi Group CEO Marco Ruini will join the UPS Healthcare leadership team and transition to a new role leading distribution and operations in southern Europe and Latin America. UPS Healthcare customers now have access to 216 facilities with a total of over 1.5 million square metres of cGMP and GDP-compliant healthcare distribution space in 37 countries and territories.
‘Together with Marco Ruini and the Bomi team, UPS Healthcare will deliver even more sophisticated and globally integrated solutions to our customers throughout Europe and Latin America’, said Kate Gutmann, Executive Vice President and President of UPS International, Healthcare and Supply Chain Solutions. ‘Our combined teams, vehicles, and advanced facilities will allow us to expand our pan-European cold chain network and bring the next generation of healthcare logistics solutions to our customers."
The UPS Healthcare team has developed a detailed transition plan to support the continued growth of the business while further connecting cold chain capabilities to major European and Latin American gateways.
‘With the capabilities Bomi Group brings to our network, UPS Healthcare is confident that significant new services and synergies will come from this acquisition in Europe and Latin America’, said UPS Healthcare President Wes Wheeler. ‘As we move into our transition plan, we will be executing with the best structure to optimise our joint capabilities. We are ready to put those synchronised services into action.’
UPS Healthcare delivers unparalleled healthcare logistics expertise to its customers around the world. UPS Healthcare has over 1.5 million square metres of cGMP and GDP-compliant healthcare distribution space in 37 countries and territories. Its services include inventory management, cold chain packaging and shipping, storage and fulfilment of medical devices, and lab and clinical trial logistics. UPS Healthcare's global infrastructure, its UPS® Premier visibility service, its track and trace technology, and its global quality system are well-suited to meeting today's complex logistics demands for the pharmaceutical, medical device, and laboratory diagnostic industries.
UPS (NYSE: UPS) is one of the world's largest companies, with 2021 revenue of $97.3 billion, and provides a broad range of integrated logistics solutions for customers in more than 220 countries and territories. Focused on its purpose statement, ‘Moving our world forward by delivering what matters’, the company's more than 500,000 employees embrace a strategy that is simply stated and powerfully executed: Customer First. People Led. Innovation Driven. UPS is committed to reducing its impact on the environment and supporting the communities we serve around the world. UPS also takes an unwavering stance in support of diversity, equity and inclusion. More information can be found at www.ups.com, about.ups.com and www.investors.ups.com.
UPS to Acquire Multinational Healthcare Logistics Provider Bomi Group
Marken reaches agreement to acquire the medical courier business of Cedra Express
UPS Healthcare Revolutionises Prioritised Shipping with Enhancements to UPS® Premier